ProCE Banner Activity


Patient-Centered Solutions: Individualized Treatment, Counseling, and Medication Management in Migraine Care


Migraine is a chronic disorder that affects more than 1 billion people worldwide. In this Medical Minute, healthcare professionals will learn strategies to enhance patient-centered migraine care, including how to individualize treatment, counseling, and medication management.

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Nurses: 0.50 Nursing contact hour

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Pharmacists: 0.50 contact hour (0.05 CEUs)

Released: March 12, 2024

Expiration: March 11, 2025



Abigail L. Chua

Abigail L. Chua, DO

Headache Subspecialist
Director of Neurology
Geisinger Wyoming Valley Medical Center
Wilkes-Barre, Pennsylvania

Nada Hindiyeh

Nada Hindiyeh, MD, FAHS

Director, Headache Neurology
Metrodora Institute
Chief Medical Officer
Haven Headache and Migraine Cneter
West Valley City, Utah

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by educational grants from AbbVie Inc., Lundbeck and Pfizer, Inc.

AbbVie Inc.


Pfizer, Inc.

Target Audience

This program is intended for healthcare professionals caring for patients with migraine, including headache specialists, neurologists, nurse practitioners, physician associates/physician assistants, and pharmacists.

Program Learning Goal

The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with migraine

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify patient and disease state criteria that determine appropriateness for preventive treatment of migraine

  • Create an individualized, proactive treatment plan for migraine prevention using shared decision-making with a patient who qualifies for preventive treatment


Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Abigail L. Chua, DO

Headache Subspecialist
Director of Neurology
Geisinger Wyoming Valley Medical Center
Wilkes-Barre, Pennsylvania

Abigail L. Chua, DO: consultant/advisor/speaker: AbbVie.

Nada Hindiyeh, MD, FAHS

Director, Headache Neurology
Metrodora Institute
Chief Medical Officer
Haven Headache and Migraine Cneter
West Valley City, Utah

Nada Hindiyeh, MD, FAHS: consultant/advisor/speaker: AbbVie, Impel, Lilly.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose, except Michael Asbach, DMSc, PA-C, as noted below.

Michael Asbach, DMSc, PA-C: consultant/advisor/speaker: AbbVie, Avanir, Intracellular, Janssen, Neurocrine, Otsuka, Sage/Biogen.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.5 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 12, 2024, through March 11, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.


This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.5 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 0.5 contact hours (0.05 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-24-078-H01-P

Type of Activity: Knowledge

Upon successfully completing the post-test with a score of 65 or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days. 

Physician Associate Continuing Medical Education

LogoDescription automatically generated

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until March 11, 2025. PAs should only claim credit commensurate with the extent of their participation.